Ticker Scorecard - VOR Basics Company: Vor Biopharma Inc. Common Stock IPO Date: February 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $170.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 4.25% Avg Daily Range (30 D): $0.06 | 4.05% Avg Daily Range (90 D): $0.05 | 4.70% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .46M Avg Daily Volume (90 D): .55M Trade Size Avg Trade Size (Sh.): 144 Avg Trade Size (Sh.) (30 D): 265 Avg Trade Size (Sh.) (90 D): 370 Institutional Trades Total Inst.Trades: 79 Avg Inst. Trade: $2.64M Avg Inst. Trade (30 D): $.61M Avg Inst. Trade (90 D): $.61M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.72M Avg Closing Trade (30 D): $3.76M Avg Closing Trade (90 D): $3.76M Avg Closing Volume: 464.25K     News Jan 8, 2025 @ 2:00 PM Vor Bio Appoints Life Sciences and Technology Inve... Source: N/A Dec 27, 2024 @ 2:00 PM Vor Bio Announces $55.6 Million Private Placement Source: N/A Sep 30, 2024 @ 11:00 AM Vor Bio Appoints Seasoned Healthcare Institutional... Source: N/A Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com Jun 4, 2024 @ 8:01 PM Vor Bio Reports Inducement Grant Under Nasdaq List... Source: Vor Biopharma Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.64 $-.4 $-.41 Diluted EPS $-1.64 $-.4 $-.41 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -112.46M $ -27.56M $ -27.84M Operating Income / Loss $ -118M $ -28.51M $ -29.04M Cost of Revenue $ $ $ Net Cash Flow $ 7.77M $ -23.28M $ 31.11M PE Ratio